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A B S T R A C T
Background: Tp47 can induce immune cells to produce numerous inflammatory factors, some of which can
trigger autophagy. Increased autophagy has a dual effect on cell survival. However, whether Tp47 induces
autophagy in microglia is unknown.
Objective: To evaluate the potential role of Tp47 in microglia.
Methods: After treatment with Tp47, autophagy-related proteins were assessed in HMO6 human microglial cells
by flow cytometry, Western blotting and immunofluorescence. Cell death was assessed by flow cytometry and
trypan blue staining. Changes in mTOR pathway proteins were explored by using Western blotting.
Results: After treatment with Tp47, a gradual increase in total LC3 expression was observed as a dose- and time-
dependent accumulation of its active form, LC3-II (P < 0.05), but P62 expression was downregulated
(P < 0.05). Moreover, microglial mortality gradually increased in a dose- and time-dependent manner. 3-
Methyladenine (3-MA), a specific inhibitor of PI3KC3, reversed autophagy and cell death. The mortality rate of
HMO6 microglial cells treated with Tp47 was approximately 13.7 ± 2%, and the basal expression of p-mTOR,
p-p70s6k and p-S6 in these cells was significantly downregulated by Tp47. Moreover, the mortality rate of
microglia was significantly reduced after mTOR agonist intervention.
Conclusion: In human microglial HMO6 cells, Tp47 induces autophagy- and mTOR pathway-dependent cell
death.
1. Introduction
Syphilis remains the most common sexually transmitted disease;
neurosyphilis is one of the most destructive clinical types of syphilis and
is difficult to control. The high prevalence of syphilis leads to a con-
tinuous increase in the incidence of neurosyphilis. Approximately 70%
of patients with syphilis show cerebrospinal fluid abnormalities, and
25–40% of untreated or partially treated patients may develop neuro-
syphilis [1]. Neurosyphilis can occur at any stage of syphilis, and its
most common form is asymptomatic neurosyphilis following the inva-
sion of the central nervous system (CNS) by Treponema pallidum [2].
Asymptomatic cases may create diagnostic problems and become a
potential source of infection, leading to incorrect therapeutic decision,
causing some scholars to speculate that the incidence of neurosyphilis
may be higher than reported.
Asymptomatic neurosyphilis patients have high concentrations of
Tp47, the membrane protein of Treponema pallidum, in the cere-
brospinal fluid [3]. Membrane proteins are recognized as Treponema
pallidum virulence factors. Among these proteins, Tp47 is the most
abundant in T. pallidum and shares no sequence homology with any
other bacterial or eukaryotic protein [4], which typically form the ac-
tive center of penicillin-binding protein. Lewis et al. has been reported
the Tp47 antigen may be a potential marker for active syphilis disease
as presented in all stages of non-treated syphilis [5,6]. Study has found
that Tp47 - the abundant membrane immunogens of T. pallidum - is
proteolipids, which may serve to explain their extraordinary im-
munogenicity [7]. Timothy et al. also found that Tp47 caused immune
cells such as macrophages to produce numerous inflammatory factors,
such as TNF-α and IL-8 [8], and these inflammatory factors can trigger
autophagy [9].
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Autophagy is an evolutionarily conserved process that plays a major
role in various stimulus responses, such as cellular responses to host
defence, starvation, cell survival and cell death [10]. This process of
self-digestion is widely believed to exert a dual effect— cytoprotection
and cytotoxicity—on cell survival [11]. Moreover, accumulating studies
have shown that autophagy is involved in the processing of pathogenic
bacteria by microglia [12].
Microglia, the resident macrophages within the CNS, play an im-
portant role in maintaining brain microenvironment homeostasis by
continuously surveying tissue damage [13]. Mirco et al. found that
neurosyphilis patients showed cortical susceptibility-weighted imaging
hypointensity, unlike patients with other infectious or inflammatory
diseases of the CNS. The authors speculated that the cortical low-den-
sity signalling in patients with neurosyphilis may be associated with
abnormal microglial function [14].
Studies have found that lipopolysaccharide (LPS) can cause micro-
glia to produce numerous inflammatory factors and induce autophagy
in cells and that excessive autophagy stimulates the autophagic death of
cells [15]. Tp47 is abundant in patients with neurosyphilis [4,16],
prompting the question of whether Tp47 can induce autophagy in mi-
croglia. The mechanism of the relationship between Tp47 and im-
portant immune defences in microglial cells of the nervous system is
still unclear. In this study, we aim to evaluate the potential role of Tp47
in microglia and to investigate whether autophagy is involved in the
processing of pathogenic Tp47 by microglia.
2. Materials and methods
2.1. Preparation of the recombinant T. pallidum Tp47 protein
Endotoxins were removed from the recombinant T. pallidum Tp47
protein (Boson Biotech Co., Ltd., Xiamen, China) with an EtEraserTM
Endotoxin Removal Kit (Chinese Horseshoe Crab Reagent Manufactory,
Ltd., Xiamen, China). Tachypleus amebocyte lysate (Chinese Horseshoe
Crab Reagent Manufactory, Ltd., Xiamen, China) was used to detect
endotoxins in the Tp47 preparation, which was found to have<0.05
endotoxin units (EUs)/mL.
2.2. Cell culture and treatment
HMO6 (Columbia University) cells, an immortalized human mi-
croglial cell line, were grown in Dulbecco's modified Eagle's medium
(DMEM, HyClone, Logan, Utah, USA) with high glucose supplemented
with 10% heat-inactivated foetal bovine serum (FBS, Biological
Industries Ltd., Kibbutz Beit Haemek, Israel) and incubated at 37 °C
with 5% CO2. The cells used for the tests were assessed for viability
using trypan blue (Sigma) under an Olympus (USA) microscope; only
cells with> 95% viability were used in the experiments.
Cells treated with PBS were used as the control. Tp47 was used
alone at the following concentrations: 1) 100 μg/mL, 2) 150 μg/mL, or
3) 200 μg/mL. Concurrently, the autophagy and mortality of microglia
were observed by adding the inhibitor 3-methyladenine (3-MA) (1mM)
dissolved in PBS used to pretreat the cells for 1 h. 3-MA was purchased
from Sigma-Aldrich (St. Louis, MO, USA).
2.3. Flow cytometry test
Cells were seeded in a 6-well plate, and after different durations (0,
6, 12, 24 and 48 h), the cells were collected and washed twice with PBS,
suspended in binding buffer and incubated with FITC-conjugated an-
nexin V and propidium iodide (PI) (Sigma) for staining at room tem-
perature for 15min in the dark. Apoptotic cells were quantified by flow
cytometry (BD Biosciences, San Diego, USA). Cells were plated in 3-cm
dishes and treated with Tp47 (200 μg/mL) or an equal amount of PBS
for 24 h. Then, the cells were fixed and lysed. Mouse anti-human LC3-
APC (Cell Signalling Technology, Beverly, MA, USA) was used as a
marker for the staining of autophagy-related proteins. Flow cytometry
was performed using a BD Biosciences FACSCanto II flow cytometer
(BD Biosciences).
2.4. Western blot (WB) analysis
Cells were treated with 200 μg/mL Tp47 in a 6-well plate. Then,
cells were collected after 24 h for WB analysis. WB analysis was per-
formed according to the method previously described in the literature
[17], and 20 μg of total protein per lane was loaded onto sodium do-
decyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels and
transferred onto polyvinylidene difluoride (PVDF) membranes (Bio-
Rad). After blocking using 5% nonfat milk for 1 h, membranes were
incubated overnight at 4 °C with the primary antibodies (rabbit anti-
human LC3, rabbit anti-human P62, rabbit anti-human β-actin, rabbit
anti-p-mTOR, rabbit anti-p70s6k and rabbit anti-p-S6) and the sec-
ondary antibody (an anti-rabbit horseradish peroxidase-conjugated
antibody) at dilutions of 1:1000 and 1:5000, respectively. The images
were quantified using ImageJ software. Antibodies against LC3, P62,
mTOR, p70s6k, S6 and β-actin were purchased from Cell Signalling
Technology (Beverly, MA, USA).
2.5. Fluorescence confocal microscopy test
Cells were seeded on coverslips in 12-well plates. After 24 h of
growth, cells were transiently transfected with the pmCherry-EGFP-LC3
plasmid with Lipofectamine 3000 transfection reagent according to the
manufacturer's protocol. After 72 h, the cells were treated with Tp47.
After treatment for 24 h, the cells were viewed under an LSM700 con-
focal laser scanning microscope (Zeiss, Oberkochen, Germany). The
percentage of cells with more than five LC3 puncta, which were con-
sidered autophagic vacuoles, was quantified. Lipofectamine® 3000 was
purchased from Life Technologies, and pmCherry-EGFP-LC3 was ob-
tained from MiaoLingBio.
2.6. Statistical analysis
The data are expressed as the means± standard errors of the mean
(SEMs) of at least three independent experiments. Statistical sig-
nificance between two groups was determined using Student's t-test
(paired t-test for clinical samples and unpaired t-test for all other
samples). For comparisons of multiple groups, one-way ANOVA fol-
lowed by a Bonferroni-Dunn test was used. Statistical analyses were
performed using PRISM version 6.0 (GraphPad Software, San Diego,
CA). A P value of< 0.05 was considered statistically significant.
3. Results
3.1. Tp47 induces autophagy in microglia
LC3 is reliably associated with autophagosomes and is widely used
to assess autophagy. After treatment of the cells with Tp47 at con-
centrations of 0, 100, 150, and 200 μg/mL for 24 h, the relative fold
changes in LC3-II expression were 1.0 ± 0.1%, 2.2 ± 0.5%,
2.3 ± 0.3% and 3.2 ± 0.6%, respectively; the corresponding relative
fold changes in P62 expression were 2.5 ± 0.3%, 2.0 ± 0.2%,
1.3 ± 0.3% and 1.1 ± 0.2%. The immunoblot showed a gradual in-
crease in total LC3 expression by the dose-dependent accumulation of
its active form, LC3-II (P < 0.05), but P62 expression was down-
regulated (P < 0.05) (Fig. 1A). Next, we observed the autophagy of
cells treated with Tp47 in a kinetic evaluation. The relative fold
changes in LC3-II expression at 0 h, 6 h, 12 h, and 24 h after treatment
with 200 μg/mL Tp47 were 1.0 ± 0.1%, 2.1 ± 0.4%, 2.5 ± 0.7% and
3.5 ± 0.8%, respectively. Under the same conditions, the relative fold
changes in P62 expression were 2.8 ± 0.1%, 2.5 ± 0.4%, 2.0 ± 0.2%
and 1.2 ± 0.1%. LC3-II expression increased with time, and P62
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Fig. 1. Evident autophagy was observed in
microglial cells stimulated with Tp47.
(A and B) LC3 and P62 expression in HMO6
cells, as determined by immunoblotting.
HMO6 cells were incubated with different
concentrations of Tp47 for 24 h or with
200 μg/mL Tp47 for different durations
(expression levels are normalized to that of
β-actin). *P < 0.05, **P < 0.01 compared
with control cells. (C) Cells were transfected
with pmCherry-GFP-LC3 for 72 h followed
by treatment with Tp47. Fluorescence sig-
nals were visualized by confocal immuno-
fluorescence microscopy. The arrows in-
dicate the presence of LC3 puncta in cells.
Scale bar, 250 μm. Quantification of cells
containing LC3 puncta in HMO6 cell. (D)
LC3 levels were detected by flow cytometry
after treatment with Tp47 (200 μg/mL for
24 h) *P < 0.05, **P < 0.01.
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expression decreased with increasing autophagic flow (P < 0.05).
Compared with the LC3-II levels at 0 h, the LC3-II levels increased
significantly after treatment for 12 h and 24 h, while the P62 levels
were significantly decreased (Fig. 1B).
To visualize the formation of autophagic vacuoles, expression vec-
tors for the green and red fluorescent proteins mCherry-EGFP-LC3
(pmCherry-EGFP-LC3) were used, and the presence of pmCherry-EGFP-
LC3-labelled structures was examined. Our results showed an increase
in pmCherry-EGFP-LC3 puncta, which represented autophagic va-
cuoles, after Tp47 treatment relative to that in the control cells
(Fig. 1C).
To further demonstrate the occurrence of autophagy, we used flow
cytometry to detect the expression of the autophagy-related protein LC3
in the cytoplasm. The percentage of LC3 positive cells among the Tp47-
induced cells was significantly higher than that among the control cells
(14.8 ± 0.2% vs. 5.1 ± 0.3%, P < 0.01, Fig. 1D).
3.2. Tp47 induces microglial cell death in a dose- and time-dependent
manner
We evaluated the effect of Tp47 on human microglial cell survival.
After treatment of the cells with Tp47 at concentrations of 0, 100, 150,
and 200 μg/mL for 24 h, the cell death rates were 2.3 ± 1.0%,
2.9 ± 0.3%, 5.9 ± 0.3% and 10.8 ± 2.0%, respectively, resulting in
a significant increase in cell death at the concentration of 200 μg/mL
(P < 0.05) (Fig. 2A). Then, the time-course analysis showed that the
mortality of microglia at 0 h, 6 h, 12 h, 24 h and 48 h after treatment
with 200 μg/mL Tp47 was 2.0 ± 0.3%, 4.2 ± 0.4%, 8.6 ± 1.9%,
11.8 ± 2.0%, and 19.3 ± 3.0%, respectively. The kinetic evaluation
of annexin V vs. PI staining using flow cytometry indicated that 200 μg/
mL Tp47 significantly increased microglial cell death at 12 h post
treatment (Fig. 2B).
Next, we used trypan blue to further confirm microglial activity
after stimulation with 0, 100, 150, or 200 μg/mL Tp47 for 24 h. As
shown in Fig. 2C, the mortality of microglia at these concentrations was
2.0 ± 0.9%, 3.0 ± 0.8%, 5.6 ± 1.9% and 11.3 ± 2.3%, respec-
tively. When microglia were treated with 200 μg/mL Tp47, the rate of
cell death was significantly increased compared to that in control cells
(P < 0.05) (Fig. 2C). In addition, after microglia were incubated with
Tp47 at a concentration of 200 μg/mL for 0 h, 6 h, 12 h, 24 h or 48 h,
the mortality of microglia was 2.0 ± 0.6%, 4.5 ± 0.4%, 9.6 ± 1.7%,
12.8 ± 2.0%, and 18.3 ± 3.0%, respectively. Cell death levels sig-
nificantly increased at 12 h post treatment. (P < 0.001) (Fig. 2D), si-
milar to the above flow cytometry results.
3.3. Autophagy is required for Tp47-induced microglial cell death
To further confirm the occurrence of autophagy, we pretreated
microglial cells with 3-MA, a specific inhibitor of PI3KC3, for 1 h before
treatment with Tp47. After treatment of the microglial cells with
200 μg/mL Tp47 for 24 h, the relative fold change in LC3-II expression
was significantly decreased and that of P62 expression was significantly
increased compared with the LC3-II and P62 expression in microglial
cells not pretreated with 3-MA (2.8 ± 0.7% vs. 1.7 ± 0.2% and
0.7 ± 0.1% vs. 1.8 ± 0.3%, respectively) (Fig. 3A).
To further confirm this observation, HMO6 cells were transfected
with an mCherry-EGFP-LC3 plasmid, which was a useful assay to
monitor autophagy flux. The green fluorescence signal (EGFP) was
quenched by the low pH inside the lysosomal lumen, whereas the red
signal (mCherry) exhibited more stable fluorescence in acidic condi-
tions, in cells treated with Tp47 alone or in combination with 3-MA.
Fluorescent microscopic analyses showed that although Tp47 notice-
ably increased the formation of LC3 puncta, an indicator of autophagic
vacuoles, pretreatment with 3-MA appreciably reduced the formation of
LC3 puncta. This result demonstrated that Tp47-induced autophagy
could be partially inhibited by 3-MA (Fig. 3B).
Next, by flow cytometry, we examined the cell death rate after
treatment with autophagy inhibitors. The Tp47-induced microglial cell
death was partly blocked by 3-MA; the mortality rate of microglia de-
creased from approximately 13.8 ± 0.9% to 8.1 ± 0.7% (P < 0.05)
(Fig. 3C).
3.4. Basal expression of p-mTOR, p-p70s6k and p-S6 in HMO6 is
significantly downregulated by Tp47
Our results revealed that the basal phosphorylation levels of mTOR,
p70s6k and S6 gradually decreased over time in microglial cells treated
with Tp47. As shown in Fig. 4A, the relative ratios of p-mTOR/mTOR
after Tp47 treatment for 0 h, 6 h, 12 h and 24 h were 1.0 ± 0.2,
0.9 ± 0.1, 0.65 ± 0.1, 0.35 ± 0.1; those of p-p70s6k/p70s6k were
1.1 ± 0.1, 0.86 ± 0.15, 0.66 ± 0.1, 0.39 ± 0.1; and those of p-S6/
S6 were 1.1 ± 0.09, 0.82 ± 0.06, 0.64 ± 0.08, 0.26 ± 0.02, re-
spectively. The relative fold change in the p-mTOR/mTOR, p-p70s6k/
p70s6k and p-S6/S6 ratios after treatment with Tp47 for 12 h and 24 h
were significantly lower than those at 0 h (P < 0.05). Next, cells were
pretreated with salidroside, an agonist of mTOR, for 1 h before treat-
ment with Tp47. After treatment of the microglial cells with 200 μg/mL
Tp47 for 24 h, the p-mTOR/mTOR ratio was higher than that in mi-
croglial cells not pretreated with salidroside (0.7 ± 0.2 vs. 0.4 ± 0.1,
P < 0.05). The quantification of the staining intensity is shown on bar
graphs (Fig. 4B). Furthermore, we used flow cytometry to test the effect
of mTOR agonist treatment on Tp47-induced cell death. When Tp47
was applied to microglia, the microglia mortality rate was approxi-
mately 13.7 ± 2%. However, adding salidroside 1 h before Tp47
treatment decreased the microglial mortality rate to 9.9 ± 1%. Thus,
the mortality rate of microglia was significantly reduced after mTOR
agonist intervention. (Fig. 4C).
4. Discussion
Tp47 is a membrane protein that is highly immunogenic and is
widely used in the diagnosis of Treponema pallidum [5]. Although there
is a high concentration of Tp47 protein in the cerebrospinal fluid of
patients with neurosyphilis [16], neurosyphilis patients often present
with no symptoms of infection, i.e., asymptomatic neurosyphilis [18].
However the brain tissue specimens of patients with neurosyphilis are
difficult to obtain due to ethical concerns and many other reasons;
What is more, the animal model of Treponema pallidum is New Zealand
rabbits, and there are few antibodies to rabbits on the market, which
largely limits the development of syphilis research. Studies have found
that microglia participate in the pathogenesis of neurosyphilis [19].
Microglial cells manage the innate and adaptive immune responses not
only during CNS repair but also during various pathological processes
[20]. However, the role of Tp47 in microglia is unclear. Recently, an
observation showed that active microglia can clear pathogenic bacteria
via autophagy, thereby promoting tissue repair and regulating the re-
sponse to pathogens [21].
In our study, we found that Tp47 promoted autophagy in microglia.
Our results showed that the protein level of LC3-II gradually increased
and that of P62 decreased with the therapeutic concentration of Tp47
and extended incubation durations. This result suggested that autop-
hagy occurred in Tp47-treated HMO6 cells in a dose- and time-depen-
dent manner. LC3 is reliably associated with autophagosomes and is
widely used to assess autophagy. LC3 often exhibits a molecular con-
version from cytosolic LC3-I into its enzymatic LC3-II counterpart,
which is bound to the membrane of autophagosomes during autophagy
[11]; the autophagy receptor P62 then interacts with LC3-II at the
forming autophagosome and is degraded by autophagy, which makes
P62 another useful marker of autophagy [22]. Autophagy is a funda-
mental catabolic process that degrades cellular contents and recycles
damaged organelles [23]. According to its different mechanisms, au-
tophagy can be divided into macroautophagy, microautophagy and
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Fig. 2. Tp47 induced HMO6 human microglial cell death in a dose- and time-dependent manner.
HMO6 (5× 105 cells per well) cells were seeded in 12-well plates for 12 h and were then incubated with the indicated concentrations of Tp47 for 24 h or with 200 μg/
mL Tp47 for the indicated durations. (A) and (B) Cells were stained with annexin V-FITC/PI to analyse cell apoptosis by flow cytometry. (C) and (D) Trypan blue dye
was used to stain the cells and analyse the death ratio. Data from three independent tests are presented as the means± SEMs compared with untreated cells.
*P < 0.05, **P < 0.001.
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Fig. 3. Autophagy was required for Tp47-induced HMO6 cell
death.
(A) Cells were pretreated with 3-MA (1mM) for 1 h followed
by treatment with Tp47 (200 μg/mL for 24 h). The data in the
bar graph are the relative abundance of the LC3-II and p62
proteins in three experiments. (B) Autophagosomes were
viewed by using a confocal fluorescence microscope. The
arrows indicate the presence of LC3 puncta in cells. Scale bar,
250 μm. Quantification of cells containing LC3 puncta in
HMO6 cells (C) HMO6 cells incubated with 3-MA for 1 h at
37 °C were cultured in the presence or absence of Tp47 for
24 h and were then costained with annexin V-FITC/PI and
analysed by flow cytometry. The data in the bar graphs are
the means± SEMs of 3 separate experiments. *P < 0.05,
**P < 0.001 vs. unstimulated cells.
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molecular chaperone-mediated autophagy. Macroautophagy (com-
monly referred to simply as autophagy) involves a double- or multi-
membrane-bound structure, which is termed the autophagosome or
autophagic vacuole. The vacuolar membrane (referred to as the au-
tophagosome) fuses with the lysosome to deliver the contents into the
organelle lumen, where they can be degraded, and the resulting
macromolecules are recycled [24]. Under normal physiological condi-
tions, cells preserve a low basal rate of autophagy to maintain home-
ostasis [25]. However, autophagy is increased in response to various
stimuli and stresses. Moreover, recent studies show that autophagy a
crucial weapon in the host cell defence against bacterial and viral in-
vasion. For example, the HIV proteins TAT, NEF and ENV are involved
Fig. 4. Analysis of p-mTOR, p-p70s6k and pS6 expression levels in HMO6 cells.
(A). Cells were treated for various durations with Tp47 alone, and the expression of p-mTOR, p-p70s6k, p-pS6, and β-actin expression was assessed via Western blot
analysis. (B) and (C) HMO6 cells were pretreated with salidroside (10 μg/mL) for 1 h prior to treatment with Tp47 (200 μg/mL) for a 24 h. p-mTOR protein levels
were determined by immunoblotting, and cell viability was measured by flow cytometry. *P < 0.05, **P < 0.01.
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in stimulating autophagy [26]. However, intracellular pathogens, in-
cluding Mycobacterium tuberculosis (Mtb), have specialized anti-autop-
hagy adaptations that allow them to block, prevent, or elude autop-
hagic elimination [27]. In our study, we dynamically observed the
formation and degradation processes of autophagosomes, i.e., autop-
hagic flow, by immunofluorescence. The formation of puncta of the
mCherry-EGFP-LC3 fusion protein was observed to be significantly in-
creased after Tp47 treatment. mCherry-EGFP-LC3 is a well-character-
ized marker for visualizing autophagosomes. However, the exact me-
chanism regulating the autophagy induced by Tp47 has not yet been
clarified. Like LPS, Tp47 is highly immunogenic and induces immune
cells to produce large amounts of inflammatory factors [28], which
serve an important trigger of autophagy. For example, the cytokines
IFNγ and TNF generally upregulate autophagy in target cells, and IL1β
can activate autophagy through a mechanism similar to that of LPS
[29,30].
Although autophagy is considered a cytoprotective process under
most conditions, increasing numbers of researchers have correlated
increased autophagy with cell death under some conditions [31]. This
process of self-digestion is widely believed to have a dual effect—cy-
toprotection and cytotoxicity—on cell survival. Evidence suggests that
autophagy promotes either cell survival or cell death depending on the
type of cell, the particular environment, the presence of a stimulus, and
the duration and intensity of the stimulus [11]. An increasing number
of studies have shown that pathogens can cause autophagy and even
autophagic death in vivo. Recently, the autophagic-lysosomal com-
partment has been shown to be involved in the initiation of pro-
grammed cell death, namely, autophagic cell death (ACD) [32]. Large
cytosolic autophagic vacuoles from accumulated autophagosomes,
which are marked by LC3 labelling, are the most prominent char-
acteristics of ACD. Based upon our observations and these concepts, we
hypothesized that autophagy may determine microglial HMO6 cell fate
under exposure to Tp47; we therefore examined the survival of these
cells in the context of robust autophagy induction by Tp47. The results
showed that cell death increased with autophagy and that this process
was reversed by autophagy inhibitors, indicating that the induction of
autophagy was involved in the mechanism of Tp47-induced microglial
death and demonstrating that Tp47 stimulation may trigger autophagic
cell death in microglial cells. However, the mechanism by which Tp47
induces autophagic death in microglia is unclear. Iribarren et al. de-
monstrated that some immunogenic substances, such as LPS and pep-
tidoglycan, can cause autophagic death in some cells, and autophagic
death mechanisms are involved in the means by which some anticancer
drugs clear tumour cells. The prolonged and excessive activation of
microglia can lead to changes in function and even evolve into autop-
hagic death [33]. Moreover, the pathogenesis of Treponema pallidum has
been found to involve cell death [34]. The Tp47 protein may play an
important role in the mechanism of cell death caused by Treponema
pallidum.
Another question is whether the mechanism by which Tp47 causes
microglial autophagy death is associated with the mTOR pathway.
Given the vital role of the mTOR pathway in regulating cell survival/
death/autophagy in response to external stimuli, we investigated the
effect of Tp47 on mTOR pathway protein expression in HMO6 micro-
glial cells. Our results demonstrated that Tp47 decreased the basal
phosphorylation level of mTOR. Salidroside, an agonist of mTOR, can
improve muscle nutrition by increasing mTOR, p-mTOR, and MyHC
expression [35]. However, the cell mortality was not significantly re-
duced after using the mTOR agonist (salidroside) compared with that
seen with inhibition by 3-MA using autophagy as an indicator. Thus,
Tp47 may cause cell death via multiple mechanisms involving autop-
hagic cell death and the inhibition of the mTOR pathway. The mTOR
pathway is an important signalling pathway that regulates autophagy.
In the initial stage of autophagy, mTOR activity is inhibited by up-
stream genes, thereby activating the downstream target gene Ulk1 [36].
Activation of Ulk1 induces the formation of the Atg complex and
completes the construction of the basic autophagosome structure. In
addition, the complex promotes the conversion of LC3-I to LC3-II, and
LC3-II is then transported to the cell membrane via Atg7 and Atg3 to
complete the formation of autophagosomes [37]. Our research de-
monstrated that Tp47 induces autophagic death in microglia. This
finding further clarifies the mechanisms underlying the immune escape
and long-term chronic infection of Treponema pallidum, thus providing a
basis for the clinical treatment of syphilis.
In conclusion, we demonstrated that autophagy was induced in
human microglial cells by Tp47 and that cell death occurred after Tp47
treatment. This mechanism of death involves autophagy and the mTOR
pathway, which is itself involved in the mechanism of autophagic
death. Further investigations will augment our understanding of the
role of autophagy in pathogenesis and the management of neurosy-
philis.
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